Fundraising FoxSPRINGROCK VENTURES — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Third Eye Health operates a network of board-certified physicians providing virtual post-acute care and after-hours coverage for skilled nursing facilities and patients, using mobile technology and care coordination services.
Digital HealthHealthtechChicago, US
Daniel Herbstman(Executive Officer, Director, Promoter)Jamison Feramisco(Director)Lucas Baran(Executive Officer, Director, Promoter)
BoardMichael Sachs(Director)
Board seatKirsten Morbeck· per SEC Form D
Co-investorsA1 Health VenturesEquitage Ventures, L.L.C.Generator VenturesThird Act VenturesS1 Seed VenturesWavemaker Three-Sixty Health
DexCare provides patient access and scheduling navigation logic for health systems, enabling patients to find available appointments across multiple care entry points and improving utilization of existing capacity.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSPhiladelphia, US
Sean O'Connor(Co-Founder & President)inMatt Blosl(Chief Executive Officer)inLynne Chou O?Keefe(Director)Aaron Martin(Director)Derek Streat(Executive Officer, Director)
Co-investorsFrist Cressey VenturesICONIQTRANSFORMATION CAPITALAllumia VenturesDefine VenturesKaiser Permanente Ventures+2 more
Outbound AI builds conversational AI agents that automate phone-based administrative work in healthcare, particularly for medical billing and revenue cycle tasks.
AI & Machine LearningHealthtechSeattle, US
Jonathan Wiggs(Founder)inStead Burwell(Founder)
Co-investorsAlumni VenturesAscend Venture CapitalEPIC VENTURESKCRise FundMadrona Venture GroupAscend+3 more
Proclaim manufactures a customized oral health device that uses water pulsation to clean teeth and gums; it partners with dental professionals to create personalized mouthpieces via 3D scanning for individual users.
ConsumerHealthtechMedical DevicesMountain View, US
Mike H(Founder)Mariya Filipova(CEO)in
Co-investorsKhosla VenturesMango CapitalMarram VenturesRevere Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.